Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00967304 · ClinicalTrials.gov registry record · Phase 4
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
A Phase 4 study, sponsored by Ottawa Hospital Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,779
- Enrollment target
NCT00967304: Completed Phase 4 study, sponsored by Ottawa Hospital Research Institute.
NCT00967304 is a Phase 4 study that has completed, run by Ottawa Hospital Research Institute. The registered enrollment target is 2,779 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (436% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00967304, a Phase 4 study, has completed, sponsored by Ottawa Hospital Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,779 participants
- Enrollment target
Study Summary
The main objective of this study is to verify whether a new clinical decision rule identifying patients diagnosed with unprovoked blood clots who have a low risk of recurrence can safely stop oral anticoagulant therapy after 5-7 months of treatment.
Interventions
- OTHER Application of the"Men continue and HER DOO2" rule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,779 participants |
| Start Date | 2008-11 |
| Est. Completion | 2016-07 |
| Phase | Phase 4 |
What the finished NCT00967304 record still lists
NCT00967304 is an interventional study that assigns participants to a tested intervention. Its 2,779 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (436% higher).
The record links to 0 conditions, and to 1 intervention - of which Application of the"Men continue and HER DOO2" rule is the first listed.
NCT00967304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00967304 about?
NCT00967304 is a clinical study titled "Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism". The main objective of this study is to verify whether a new clinical decision rule identifying patients diagnosed with unprovoked blood clots who have a low risk of recurrence can safely stop oral anticoagulant therapy after 5-7 months of treatment.
What is the current status of trial NCT00967304?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,779 participants. The study started on 2008-11. Estimated completion is 2016-07.
What interventions are being tested in trial NCT00967304?
The interventions under investigation include: Application of the"Men continue and HER DOO2" rule (OTHER).
Who is sponsoring clinical trial NCT00967304?
This trial is sponsored by Ottawa Hospital Research Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00967304's enrollment target sits among peer trials
2,779 25th of 2000 higher than 1,976 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia